Clinical Trials Directory

Trials / Unknown

UnknownNCT05375383

Microbial Colonization of Oral Probiotics

Assessment of Colonisation of Probiotic Bacterium Streptococcus Salivarius in the Oral Cavity

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
BLIS Technologies Limited · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to evaluate the colonization efficacy of probiotic lozenges and powders containing specific prebiotics in healthy adults

Detailed description

This is a double-blind, randomized controlled colonization pilot study with no cross over to evaluate the colonization efficacy of lozenges and powders containing two different commercially available probiotic bacteria (S. salivarius K12 ) or S. salivarius M18 with or without 2 different prebiotic sugars or their combinations. Participants will be randomly assigned to one of the 12 groups consuming probiotic lozenge or powder containing Streptococcus salivarius K12 or S. salivarius M18 with or without prebiotics (e.g. sugars that may promote probiotic activity) over a seven day period. Saliva samples will be collected at predetermined time points pre and post intervention. Colonisation efficacy will be determined by enumerating the probiotic in the saliva samples using standard microbiological techniques.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTStreptococcus salivarius K12 lozengeIn this study, a lozenge will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity.
DIETARY_SUPPLEMENTProbiotic S. salivarius K12 lozenges containing prebiotic AIn this study, a lozenge containing a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity.
DIETARY_SUPPLEMENTProbiotic S. salivarius K12 lozenges containing prebiotic BIn this study, a lozenge containing a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity.
DIETARY_SUPPLEMENTProbiotic S. salivarius K12 lozenges containing prebiotics A and BIn this study, a lozenge containing two prebiotics will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity.
DIETARY_SUPPLEMENTProbiotic S. salivarius K12 powderIn this study, a powder will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity
DIETARY_SUPPLEMENTProbiotic S. salivarius K12 powder containing prebiotic AIn this study, a powder containing a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity
DIETARY_SUPPLEMENTProbiotic S. salivarius K12 powder containing prebiotic BIn this study, a powder containing a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity
DIETARY_SUPPLEMENTProbiotic S. salivarius K12 powder containing prebiotics A and BIn this study, a powder containing two prebiotics will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity
DIETARY_SUPPLEMENTProbiotic S. salivarius M18 lozengesIn this study, a lozenge containing will be evaluated for its potential of delivering probiotic Streptococcus salivarius M18 to the oral cavity.
DIETARY_SUPPLEMENTProbiotic S. salivarius M18 lozenges containing prebiotic AIn this study, a lozenge containing a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius M18 to the oral cavity.
DIETARY_SUPPLEMENTProbiotic S. salivarius M18 lozenges containing prebiotic BIn this study, a lozenge containing a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius M18 to the oral cavity.
DIETARY_SUPPLEMENTProbiotic S. salivarius M18 + lozenges containing prebiotic A and BIn this study, a lozenge containing two prebiotics will be evaluated for its potential of delivering probiotic Streptococcus salivarius M18 to the oral cavity.

Timeline

Start date
2022-06-15
Primary completion
2022-08-31
Completion
2022-09-15
First posted
2022-05-16
Last updated
2022-05-16

Locations

1 site across 1 country: New Zealand

Source: ClinicalTrials.gov record NCT05375383. Inclusion in this directory is not an endorsement.